Previous Close | 1.6600 |
Open | 1.8000 |
Bid | 0.9800 |
Ask | 2.8200 |
Strike | 510.00 |
Expire Date | 2024-09-20 |
Day's Range | 1.7100 - 1.8000 |
Contract Range | N/A |
Volume | |
Open Interest | 359 |
Competition is heating up in the GLP-1 space as Amgen gets closer to the finish line with its candidate.
Amazon reported strong first-quarter results, with revenue and operating income ahead of expectations. The company delivered operating income of $15.3 billion, above consensus of $11.3 billion, while reporting better-than-expected growth in both Amazon Web Services (+17.2% year over year versus Street +15%) and advertising (+24.3% Y/Y versus Street +23.5%). Amazon has now reported operating income above the high end of its guidance range for five consecutive quarters, and the company has a number of drivers for further margin expansion in place, including continued cost efficiencies within its fulfillment network as well as the ongoing mix shift toward higher-margin AWS and advertising revenue.
Amgen (AMGN) beats first-quarter 2024 estimates for earnings and sales. Amgen is "very encouraged" by interim data from the phase II study on obesity candidate MariTide.